
    
      All patients must be at least 4 weeks from cytoreductive surgery before starting treatment.
      Patients will be randomized to receive treatment with either paclitaxel/carboplatin +
      sorafenib or paclitaxel/carboplatin. Paclitaxel/carboplatin will be repeated every 21 days
      for a maximum of 6 cycles. Patients with objective response/stable disease after completing 6
      courses of chemotherapy will continue sorafenib until disease progression or for a total of
      12 months.

      - Regimen A:

      Paclitaxel 175 mg/m2 1-3 hour IV infusion, Day 1

      Carboplatin AUC 6 infused over 20 minutes IV, Day 1

      Sorafenib 400mg PO bid

      - Regimen B:

      Paclitaxel 175mg/m2, 1-3 hour IV infusion, Day 1

      Carboplatin AUC 6.0, 20 minute IV infusion, Day 1
    
  